ALLURION TECHNOLOGIES INC (ALUR) Stock News

Top movers analysis one hour before the close of the markets on 2025-02-19: top gainers and losers in today's session.

Here are the top movers in Wednesday's session, showcasing the stocks with significant price changes.

Mentions: CPIX PRPH APTO EDIT ...

Here are the top movers in Wednesday's session.

Here are the top movers in Wednesday's session, showcasing the stocks with significant price changes.

Mentions: APTO SEDG EDIT RSLS ...

Allurion Announces Closing of Offering and Concurrent Private Placement to Advance GLP-1 Clinical Pipeline

S&P 500 Edges Higher; Analog Devices Earnings Top Views

Mentions: ADI COMP SEDG SINT ...

Wednesday's session: gap up and gap down stocks

Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Wednesday. Let's explore the market movements and identify the stocks with significant gaps.

Mentions: ANDE APTO SEDG RSLS ...

Allurion to Raise Approximately $6.1 Million of Gross Proceeds in Offering and Concurrent Private Placement to Advance GLP-1 Clinical Pipeline

Allurion Announces Plans To Combine GLP-1 Therapy With The Allurion Balloon to Treat Obesity

Allurion Relaunches in France

Allurion Catapults 200% On Its Plans To Outdo Eli Lilly, Novo Nordisk

While the other companies are testing weight-loss drugs, Allurion has a different approach to obesity.

Mentions: LLY NVO

Allurion to Raise Approximately $7.4 Million of Gross Proceeds in Offering Priced At-the-Market

Allurion Announces Plans To Optimize Muscle Mass During GLP-1 Therapy In Combination With the Allurion Program

Allurion Announces Notification of Issuance of New U.S. Patent on Next-Generation Weight Loss Device for the Treatment of Obesity

Allurion Announces Private Placement of Common Stock and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2024

Allurion Announces Positive Topline Results From AUDACITY Trial

Allurion Technologies, Inc. Announces Reverse Stock Split

Allurion Announces NYSE Acceptance of Plan to Regain Listing Compliance

Allurion Launches in the US with its First AI-Native Compounded GLP-1 Program

Allurion Reports Third Quarter 2024 Financial Results and Provides Business Update

A Look Ahead: Allurion Technologies's Earnings Forecast